- Home
- PHLT vs QTRX Comparison
PHLT vs QTRX Comparison
Compare PHLT & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHLT
- QTRX
- Stock Information
- Founded
- PHLT 1976
- QTRX 2007
- Country
- PHLT United States
- QTRX United States
- Employees
- PHLT N/A
- QTRX N/A
- Industry
- PHLT Other Consumer Services
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- PHLT Consumer Discretionary
- QTRX Industrials
- Exchange
- PHLT Nasdaq
- QTRX Nasdaq
- Market Cap
- PHLT 267.0M
- QTRX 233.5M
- IPO Year
- PHLT N/A
- QTRX 2017
- Fundamental
- Price
- PHLT $4.19
- QTRX $6.98
- Analyst Decision
- PHLT
- QTRX Buy
- Analyst Count
- PHLT 0
- QTRX 5
- Target Price
- PHLT N/A
- QTRX $15.60
- AVG Volume (30 Days)
- PHLT 212.1K
- QTRX 895.5K
- Earning Date
- PHLT 08-06-2025
- QTRX 08-07-2025
- Dividend Yield
- PHLT N/A
- QTRX N/A
- EPS Growth
- PHLT N/A
- QTRX N/A
- EPS
- PHLT N/A
- QTRX N/A
- Revenue
- PHLT $128,916,000.00
- QTRX $135,688,000.00
- Revenue This Year
- PHLT $11.03
- QTRX N/A
- Revenue Next Year
- PHLT $11.23
- QTRX $14.49
- P/E Ratio
- PHLT N/A
- QTRX N/A
- Revenue Growth
- PHLT 11.76
- QTRX 7.71
- 52 Week Low
- PHLT $2.17
- QTRX $4.05
- 52 Week High
- PHLT $4.35
- QTRX $16.74
- Technical
- Relative Strength Index (RSI)
- PHLT N/A
- QTRX 64.88
- Support Level
- PHLT N/A
- QTRX $6.42
- Resistance Level
- PHLT N/A
- QTRX $7.09
- Average True Range (ATR)
- PHLT 0.00
- QTRX 0.47
- MACD
- PHLT 0.00
- QTRX 0.07
- Stochastic Oscillator
- PHLT 0.00
- QTRX 92.52
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.